发明名称 |
LIQUID PHARMACEUTICAL COMPOSITION OF CONJUGATED ERYTHROPOIETIN |
摘要 |
A liquid pharmaceutical composition having a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. The liquid pharmaceutical composition provides a stable pharmaceutical composition which encompasses conjugated erythropoietin, acetate buffer, sucrose, arginine and sodium chloride which is maintained at a pH of about 4.9 to 5.3. |
申请公布号 |
US2017112901(A1) |
申请公布日期 |
2017.04.27 |
申请号 |
US201515300504 |
申请日期 |
2015.02.27 |
申请人 |
Intas Pharmaceuticals Ltd. |
发明人 |
CHHATBAR Chandresh;PANDEY Vijaykant;CHAUHAN Nildip |
分类号 |
A61K38/18;A61K47/26;A61K47/18;A61K47/02;A61K47/12 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A liquid pharmaceutical formulation comprising: a conjugated EPO, and a buffer which is selected from the group consisiting of acetate, arginine, histidine, succinate or a combination thereof, an aggregation inhibitor, sodium chloride as tonicity modifier and sucrose as stabilizer wherein the pH of the formulation is between 4.9 to 5.3. |
地址 |
Ahmedabad IN |